http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-295548-A5
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_313c2ac1c6159e38a96bd17d83b17a2b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
filingDate | 1987-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e620162cfdaabf32e3a098fb8ebd06c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e0866e4f63244c7ad6a7fa158cc0ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a00352837e2e3a6a342b5ed8515e416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ca1fa294c8739ca18b365b006b255c |
publicationDate | 1991-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DD-295548-A5 |
titleOfInvention | METHOD FOR PRODUCING A MORPHINE MEDICAMENT WITH A SIMILARLY DELAYED ACTIVE INGREDIENT EXTRACTION |
abstract | The invention relates to a method for producing a perorally administrable sustained-release pharmaceutical formulation of morphine, in which the active ingredient is embedded in a hydrophilic matrix consisting of a mixture of polyvinyl alcohols having different vinyl acetate content and non-toxic adjuvants; it contributes significantly to the improvement of the treatment of severe and severe pain conditions, especially in cancer patients, by ensuring uniform blood levels of the active ingredient over a desired period of time, and is technologically and economically advantageous to produce {morphine; Retardarzneimittel; hydrophilic matrix; Mixture of polyvinyl alcohols; Therapy of severe and severe final pain states} |
priorityDate | 1987-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.